Actics Medical
Transforming Diabetic Care – Saving Limbs and Lives with AI-Powered, Remote Proactive Therapy
Company Overview
Snapshot
Founded in October 2020 by Ron Machanian, Actics Medical operates with 1–10 employees. The company has raised $1.3M across three funding rounds.
Business overview
Actics Medical is redefining diabetic foot care through an AI-powered platform for continuous monitoring and personalized intervention. The company's core product, the Hybrid+™ smart insole, integrates real-time pressure, temperature, and gait sensing with adaptive offloading. Actics Medical serves the healthcare industry, focusing on patients, providers, and insurance companies, and operates within the Digital Health and Medical Technologies sectors, specifically in patient remote monitoring and medical treatment.
Strategic signal
Actics Medical is advancing its AI-powered diabetic foot care solution towards clinical validation and commercialization. The company plans to launch clinical trials in early 2026 with a major US health system, which intends to adopt the Hybrid+™ smart insole after a commercial pilot. This indicates a strong market validation and a clear path to commercial adoption, positioning Actics Medical for significant impact in reducing diabetic amputations and associated healthcare costs.
Company Intelligence Q&A
- What is Actics Medical's primary product?
- Actics Medical's primary product is the Hybrid+™ smart insole, which combines real-time pressure, temperature, and gait sensing with adaptive offloading for diabetic foot care.
- What is the total capital raised by Actics Medical?
- Actics Medical has raised a total of $1.3M across three funding rounds.
- What are Actics Medical's plans for clinical trials?
- Actics Medical plans to launch clinical trials in early 2026 with a major US health system, which intends to adopt the Hybrid+™ smart insole after a commercial pilot.